Lesko Gets Answers from Members of the FDA and NIH
WASHINGTON, D.C.—U.S. Congresswoman Debbie Lesko (AZ-08) joined the House Energy and Commerce Committee’s Health Subcommittee to question members of the National Institutes of Health (NIH) on what would need to be done to ensure any expanded access program is fair for its beneficiaries and why the Food and Drug Administration approved a drug when the advisory panel was not overwhelmingly in favor ...